Industrial, Manufacturing & Heavy Industry Market News

New report shares details about the interleukin 10 pipeline product analysis

Industrial Market Research

Interleukin-10 (IL-10)-Pipeline Review Information, by product (AM-0010, ANV-103, AS-101, BT-063, DEKAVIL / F8 IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, therapies and others)

Interleukin-10, human cytokine synthesis inhibitory factor (CSIF), is group of related proteins made by leukocytes and other body cells. It is an anti-inflammatory cytokine.

IL-10 plays a key role in differentiation and function of a newly appreciated type of T cell, the T regulatory cell, which prominently control immune responses and tolerance.

Browse details of our research report on Interleukin 10 Pipeline Product Analysis Market at www.researchcosmos.com/reports/int…nd-forec/92948466 Make an Inquiry about this news

Interleukin-10 has 20 molecules in their pipeline developed by companies and universities. Interleukin 10 Pipeline Product Analysis includes products such as AM-0010, ANV-103, BT-063, DEKAVIL/F8 IL10, EG-12, LEO-32731, MK-1966, PD-2244, XT-101, XT-150, Gene Therapy to Activate Interleukin 10 for Atherosclerosis, Gene Therapy to Activate Interleukin-10 for ALS, XT-150, Gene Therapy to Activate Interleukin 10 for Atherosclerosis, Gene Therapy to Activate Interleukin-10 for ALS, Biologic to Activate Glutamic Acid Decarboxylase and IL-10 for Type 1 Diabetes, Biologic to Target Gluten and IL-10 for Celiac Disease, Cell Therapy to Activate IL-10 for Autoimmune Myocarditis and Inflammation, Synthetic Peptides to Inhibit IL-10 and IFN Gamma for Cancer, and Viral Infections and Inflammatory Diseases.

Key Findings:

  • The Interleukin-10 (IL-10) - Pipeline Review involves featured 18 products in pipeline.
  • 9 products are in preclinical trials, 4 in phase II, 2 in phase I and 2 studies were discontinued due to tolerance issues. Key Players:
  • The leading market players in the global Interleukin 10 Pipeline Product Analysis include Pfizer Inc., Merck & Co., Inc, Biotest AG, BioMAS Ltd, EnGene Inc., Leo Pharma, Anvil Biosciences, Intrexon Corporation, P2D Biosciences, Xalud Therapeutics INC and others.

Report: www.researchcosmos.com/request/92948466 Make an Inquiry about this news

Study objectives of Interleukin 10 Pipeline Product Analysis market:

  • To provide a snapshot of the global therapeutic landscape for Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10).
  • To review Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • To provide descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
  • To determine the key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics and enlists all their major and minor projects.
  • To assess Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type.

Target Audience:

  • Companies with Interleukin-10 products
  • Government Research Laboratories
  • Academic Universities/Institutes
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Report: www.researchcosmos.com/inquire/92948466 Make an Inquiry about this news

 

This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!
  • www.researchcosmos.com/reports/int…nd-forec/92948466
  • www.researchcosmos.com/request/92948466
  • www.researchcosmos.com/inquire/92948466
  • www.researchcosmos.com